Published in Pediatr Cardiol on March 06, 2013
Clinically useful predictors of resistance to intravenous immunoglobulin and prognosis of coronary artery lesions in patients with incomplete kawasaki disease. Korean Circ J (2014) 0.95
Risk factors for coronary artery abnormalities in children with Kawasaki disease: a 10-year experience. Rheumatol Int (2014) 0.87
Clinical characteristics and serum N-terminal pro-brain natriuretic peptide as a diagnostic marker of Kawasaki disease in infants younger than 3 months of age. Korean J Pediatr (2014) 0.77
Predictive factors of resistance to intravenous immunoglobulin and coronary artery lesions in Kawasaki disease. Korean J Pediatr (2016) 0.75
Epidemiological and Clinical Characteristics of Kawasaki Disease and Factors Associated with Coronary Artery Abnormalities in East China: Nine Years Experience. J Trop Pediatr (2016) 0.75
Prediction of intravenous immunoglobulin resistance in Kawasaki disease in an East China population. Clin Rheumatol (2016) 0.75
Role of the Egami score to predict immunoglobulin resistance in Kawasaki disease among a Western Mediterranean population. Rheumatol Int (2016) 0.75
Cardiac involvement in primary systemic vasculitis and potential drug therapies to reduce cardiovascular risk. Rheumatol Int (2016) 0.75
A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics (1974) 9.97
Kawasaki syndrome. Lancet (2004) 5.09
Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements. Circulation (2007) 2.76
Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. J Pediatr (2006) 2.63
Resistance to intravenous immunoglobulin in children with Kawasaki disease. J Pediatr (2008) 2.44
Epidemiologic features of Kawasaki disease in Japan: results of the 2009-2010 nationwide survey. J Epidemiol (2012) 2.15
Kawasaki disease: effect of treatment on coronary artery involvement. Pediatrics (1979) 2.08
The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment. Pediatrics (1995) 1.93
Initial intravenous gammaglobulin treatment failure in Kawasaki disease. Pediatrics (2000) 1.91
Management of Kawasaki disease in the British Isles. Arch Dis Child (1993) 1.79
Hospitalizations for Kawasaki syndrome among children in the United States, 1997-2007. Pediatr Infect Dis J (2010) 1.78
Epidemiology of Kawasaki disease in Asia, Europe, and the United States. J Epidemiol (2012) 1.70
Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment. Eur J Pediatr (2006) 1.61
Coronary artery lesions of incomplete Kawasaki disease: a nationwide survey in Japan. Eur J Pediatr (2011) 1.52
Kawasaki syndrome and risk factors for coronary artery abnormalities: United States, 1994-2003. Pediatr Infect Dis J (2006) 1.46
Short-term weather variability in Chicago and hospitalizations for Kawasaki disease. Epidemiology (2009) 1.46
Immunoglobulin failure and retreatment in Kawasaki disease. Pediatr Cardiol (2002) 1.43
Complete and incomplete Kawasaki disease: two sides of the same coin. Eur J Pediatr (2011) 1.36
Kawasaki disease in older children and adolescents. J Pediatr (2000) 1.15
Kawasaki disease. Curr Opin Pediatr (2004) 1.11
Kawasaki disease in Sweden: incidence and clinical features. Acta Paediatr (1995) 1.10
Responsiveness to intravenous immunoglobulins and occurrence of coronary artery abnormalities in a single-center cohort of Italian patients with Kawasaki syndrome. Rheumatol Int (2010) 1.10
Prevalence of superantigen-secreting bacteria in patients with Kawasaki disease. J Pediatr (2002) 1.09
Use of laboratory data to identify risk factors of giant coronary aneurysms due to Kawasaki disease. Pediatr Int (2004) 1.08
Clinical relevance of the risk factors for coronary artery inflammation in Kawasaki disease. Pediatr Cardiol (2002) 1.05
Predictive risk factors for coronary artery abnormalities in Kawasaki disease. Eur J Pediatr (2006) 1.00
Comparison of factors associated with coronary artery dilation only versus coronary artery aneurysms in patients with Kawasaki disease. Am J Cardiol (2009) 0.98
Increased incidence of incomplete Kawasaki disease at a pediatric hospital after publication of the 2004 American Heart Association guidelines. Pediatr Cardiol (2012) 0.95
Risk factors associated with the need for additional intravenous gamma-globulin therapy for Kawasaki disease. Acta Paediatr (2006) 0.86
Kawasaki disease in Israel. Pediatr Infect Dis J (2011) 0.82
Clinical characteristics of Kawasaki disease according to age at diagnosis. Indian Pediatr (2009) 0.82
Kawasaki disease in Greek children: a retrospective study. J Eur Acad Dermatol Venereol (2012) 0.75
[Kawasaki disease in children--9 years experience]. Med Wieku Rozwoj (2005) 0.75
Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med (2008) 5.30
Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psychosom Res (2002) 4.93
Noncoding RNA gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptor. Sci Signal (2010) 4.77
Insomnia with objective short sleep duration is associated with a high risk for hypertension. Sleep (2009) 4.01
Consensus statement on the use of gonadotropin-releasing hormone analogs in children. Pediatrics (2009) 2.67
Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity. Ann N Y Acad Sci (2002) 2.51
Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J (2002) 2.26
Aerobic exercise training improves insulin sensitivity without changes in body weight, body fat, adiponectin, and inflammatory markers in overweight and obese girls. Metabolism (2005) 2.24
Screening for congenital hypothyroidism: the significance of threshold limit in false-negative results. J Clin Endocrinol Metab (2010) 2.20
Cytokine dysregulation, inflammation and well-being. Neuroimmunomodulation (2005) 2.15
Sleep apnea is a manifestation of the metabolic syndrome. Sleep Med Rev (2005) 2.09
Metabolic consequences of stress during childhood and adolescence. Metabolism (2011) 2.04
Sleep, the hypothalamic-pituitary-adrenal axis, and cytokines: multiple interactions and disturbances in sleep disorders. Endocrinol Metab Clin North Am (2002) 2.02
Perceived Stress Scale: reliability and validity study in Greece. Int J Environ Res Public Health (2011) 1.99
Puberty-related influences on brain development. Mol Cell Endocrinol (2006) 1.93
Modest reversal of metabolic syndrome manifestations with vitamin D status correction: a 12-month prospective study. Metabolism (2011) 1.79
Pediatric stress: hormonal mediators and human development. Horm Res (2003) 1.79
Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications. J Clin Endocrinol Metab (2005) 1.77
Increased vitamin D supplementation recommended during summer season in the gulf region: a counterintuitive seasonal effect in vitamin D levels in adult, overweight and obese Middle Eastern residents. Clin Endocrinol (Oxf) (2012) 1.77
Diabetes mellitus type 2 and other chronic non-communicable diseases in the central region, Saudi Arabia (Riyadh cohort 2): a decade of an epidemic. BMC Med (2011) 1.76
Tissue glucocorticoid resistance/hypersensitivity syndromes. J Steroid Biochem Mol Biol (2003) 1.74
CHRONIC INSOMNIA AND STRESS SYSTEM. Sleep Med Clin (2007) 1.72
The human glucocorticoid receptor: molecular basis of biologic function. Steroids (2009) 1.69
Cyclin-dependent kinase 5 differentially regulates the transcriptional activity of the glucocorticoid receptor through phosphorylation: clinical implications for the nervous system response to glucocorticoids and stress. Mol Endocrinol (2007) 1.68
Impaired nighttime sleep in healthy old versus young adults is associated with elevated plasma interleukin-6 and cortisol levels: physiologic and therapeutic implications. J Clin Endocrinol Metab (2003) 1.63
Stress, visceral obesity, and metabolic complications. Ann N Y Acad Sci (2006) 1.62
Stress dose of hydrocortisone is not beneficial in patients with classic congenital adrenal hyperplasia undergoing short-term, high-intensity exercise. J Clin Endocrinol Metab (2004) 1.60
Interactions of the circadian CLOCK system and the HPA axis. Trends Endocrinol Metab (2010) 1.60
Adrenomedullary function may predict phenotype and genotype in classic 21-hydroxylase deficiency. J Clin Endocrinol Metab (2002) 1.57
Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome: evidence for inadequate endogenous glucocorticoid secretion and inflammation-induced immune cell resistance to glucocorticoids. Am J Respir Crit Care Med (2002) 1.52
Obesity-related sleepiness and fatigue: the role of the stress system and cytokines. Ann N Y Acad Sci (2006) 1.50
The 'self-plagiarism' oxymoron: can one steal from oneself? Eur J Clin Invest (2012) 1.49
Functional characteristics of CRH receptors and potential clinical applications of CRH-receptor antagonists. Trends Endocrinol Metab (2002) 1.46
Retracted Chronic recurrent multifocal osteomyelitis with concomitant features of juvenile idiopathic arthritis. Case Rep Rheumatol (2011) 1.40
G protein beta interacts with the glucocorticoid receptor and suppresses its transcriptional activity in the nucleus. J Cell Biol (2005) 1.37
Genome wide analysis reveals association of a FTO gene variant with epigenetic changes. Genomics (2012) 1.36
Steroid treatment in ARDS: a critical appraisal of the ARDS network trial and the recent literature. Intensive Care Med (2007) 1.36
Elevated levels of growth-related hormones in autism and autism spectrum disorder. Clin Endocrinol (Oxf) (2007) 1.34
Activation and regulation of systemic inflammation in ARDS: rationale for prolonged glucocorticoid therapy. Chest (2009) 1.32
Endothelial function, but not carotid intima-media thickness, is affected early in menopause and is associated with severity of hot flushes. J Clin Endocrinol Metab (2010) 1.32
Leptin and hunger levels in young healthy adults after one night of sleep loss. J Sleep Res (2010) 1.31
Persistent insomnia: the role of objective short sleep duration and mental health. Sleep (2012) 1.31
Brx mediates the response of lymphocytes to osmotic stress through the activation of NFAT5. Sci Signal (2009) 1.30
Pathophysiology and types of dyslipidemia in PCOS. Trends Endocrinol Metab (2007) 1.26
Beta-sitosterol exhibits anti-inflammatory activity in human aortic endothelial cells. Mol Nutr Food Res (2010) 1.25
Exercise and the stress system. Hormones (Athens) (2006) 1.24
Cardiac implications of increased arterial entry and reversible 24-h central and peripheral norepinephrine levels in melancholia. Proc Natl Acad Sci U S A (2005) 1.24
Mitochondria as key components of the stress response. Trends Endocrinol Metab (2007) 1.23
Children with classic congenital adrenal hyperplasia have elevated serum leptin concentrations and insulin resistance: potential clinical implications. J Clin Endocrinol Metab (2002) 1.22
Generalized glucocorticoid resistance: clinical aspects, molecular mechanisms, and implications of a rare genetic disorder. J Clin Endocrinol Metab (2008) 1.21
Human glucocorticoid receptor isoform beta: recent understanding of its potential implications in physiology and pathophysiology. Cell Mol Life Sci (2009) 1.21
Children with classic congenital adrenal hyperplasia have decreased amygdala volume: potential prenatal and postnatal hormonal effects. J Clin Endocrinol Metab (2003) 1.21
Glucocorticoid and mineralocorticoid receptors and associated diseases. Essays Biochem (2004) 1.20
A novel point mutation in the KCNJ5 gene causing primary hyperaldosteronism and early-onset autosomal dominant hypertension. J Clin Endocrinol Metab (2012) 1.20
Low adiponectin levels are associated with renal cell carcinoma: a case-control study. Int J Cancer (2007) 1.20
Impaired endothelial function in young women with premature ovarian failure: normalization with hormone therapy. J Clin Endocrinol Metab (2004) 1.19
Sleep-disordered breathing in obese children is associated with prevalent excessive daytime sleepiness, inflammation, and metabolic abnormalities. J Clin Endocrinol Metab (2009) 1.18
The efficacy and safety of gonadotropin-releasing hormone analog treatment in childhood and adolescence: a single center, long-term follow-up study. J Clin Endocrinol Metab (2009) 1.17
Peripheral CLOCK regulates target-tissue glucocorticoid receptor transcriptional activity in a circadian fashion in man. PLoS One (2011) 1.16
Children experience cognitive decline despite reversal of brain atrophy one year after resolution of Cushing syndrome. J Clin Endocrinol Metab (2005) 1.15
Vitamin D supplementation as an adjuvant therapy for patients with T2DM: an 18-month prospective interventional study. Cardiovasc Diabetol (2012) 1.14
Positive effects of glucocorticoids on T cell function by up-regulation of IL-7 receptor alpha. J Immunol (2002) 1.14
The glucocorticoid receptor and the orphan nuclear receptor chicken ovalbumin upstream promoter-transcription factor II interact with and mutually affect each other's transcriptional activities: implications for intermediary metabolism. Mol Endocrinol (2004) 1.13
Vpr protein of human immunodeficiency virus type 1 binds to 14-3-3 proteins and facilitates complex formation with Cdc25C: implications for cell cycle arrest. J Virol (2005) 1.13
A novel, C-terminal dominant negative mutation of the GR causes familial glucocorticoid resistance through abnormal interactions with p160 steroid receptor coactivators. J Clin Endocrinol Metab (2002) 1.13
Severe hypovitaminosis D is widespread and more common in non-diabetics than diabetics in Saudi adults. Saudi Med J (2010) 1.12
Hypertension in Cushing's syndrome. Best Pract Res Clin Endocrinol Metab (2006) 1.12
Cortisol response to ovine corticotropin-releasing hormone in a model of pregnancy and parturition in euthymic women with and without a history of postpartum depression. J Clin Endocrinol Metab (2004) 1.12
Natural glucocorticoid receptor mutants causing generalized glucocorticoid resistance: molecular genotype, genetic transmission, and clinical phenotype. J Clin Endocrinol Metab (2004) 1.11
The molecular pathogenesis of hereditary and sporadic adrenocortical and adrenomedullary tumors. J Clin Endocrinol Metab (2002) 1.11
The human glucocorticoid receptor (hGR) beta isoform suppresses the transcriptional activity of hGRalpha by interfering with formation of active coactivator complexes. Mol Endocrinol (2004) 1.11
Decreasing prevalence of the full metabolic syndrome but a persistently high prevalence of dyslipidemia among adult Arabs. PLoS One (2010) 1.11
Parent-offspring transmission of adipocytokine levels and their associations with metabolic traits. PLoS One (2011) 1.10
Divergent endocrine abnormalities in melancholic and atypical depression: clinical and pathophysiologic implications. Endocrinol Metab Clin North Am (2002) 1.10
A novel point mutation in the ligand-binding domain (LBD) of the human glucocorticoid receptor (hGR) causing generalized glucocorticoid resistance: the importance of the C terminus of hGR LBD in conferring transactivational activity. J Clin Endocrinol Metab (2005) 1.10
Adenoviral vectors can impair adrenocortical steroidogenesis: clinical implications for natural infections and gene therapy. Proc Natl Acad Sci U S A (2002) 1.10
Endocrine withdrawal syndromes. Endocr Rev (2003) 1.09
Effect of physical activity and sun exposure on vitamin D status of Saudi children and adolescents. BMC Pediatr (2012) 1.09
Neuroendocrinology of post-traumatic stress disorder. Prog Brain Res (2010) 1.08
Glucocorticoid receptor (GR) beta has intrinsic, GRalpha-independent transcriptional activity. Biochem Biophys Res Commun (2009) 1.08
The Smad6-histone deacetylase 3 complex silences the transcriptional activity of the glucocorticoid receptor: potential clinical implications. J Biol Chem (2005) 1.08
Effects of recovery sleep after one work week of mild sleep restriction on interleukin-6 and cortisol secretion and daytime sleepiness and performance. Am J Physiol Endocrinol Metab (2013) 1.07
Sleep apnoea and visceral adiposity in middle-aged male and female subjects. Eur Respir J (2012) 1.06
Stress system--organization, physiology and immunoregulation. Neuroimmunomodulation (2007) 1.06
Whole serum 3D LC-nESI-FTMS quantitative proteomics reveals sexual dimorphism in the milieu intérieur of overweight and obese adults. J Proteome Res (2014) 1.06
Visceral adiposity index is highly associated with adiponectin values and glycaemic disturbances. Eur J Clin Invest (2012) 1.06
Comparative efficacies of rifaximin and vancomycin for treatment of Clostridium difficile-associated diarrhea and prevention of disease recurrence in hamsters. Antimicrob Agents Chemother (2008) 1.05
A novel point mutation in helix 11 of the ligand-binding domain of the human glucocorticoid receptor gene causing generalized glucocorticoid resistance. J Clin Endocrinol Metab (2007) 1.05
Endocrine manifestations in Langerhans cell histiocytosis. Trends Endocrinol Metab (2007) 1.05
Nuclear receptor coactivator p160 proteins enhance the HIV-1 long terminal repeat promoter by bridging promoter-bound factors and the Tat-P-TEFb complex. J Biol Chem (2001) 1.05
Protein 14-3-3sigma interacts with and favors cytoplasmic subcellular localization of the glucocorticoid receptor, acting as a negative regulator of the glucocorticoid signaling pathway. J Biol Chem (2003) 1.04
Plasma interleukin 6 levels are elevated in polycystic ovary syndrome independently of obesity or sleep apnea. Metabolism (2006) 1.04
Low- versus high-baseline epinephrine output shapes opposite innate cytokine profiles: presence of Lewis- and Fischer-like neurohormonal immune phenotypes in humans? J Immunol (2008) 1.03
The natural history of neuroendocrine changes in pediatric posttraumatic stress disorder (PTSD) after motor vehicle accidents: progressive divergence of noradrenaline and cortisol concentrations over time. Biol Psychiatry (2007) 1.03
Irisin as a predictor of glucose metabolism in children: sexually dimorphic effects. Eur J Clin Invest (2013) 1.03
Elevated total and central adiposity and low physical activity are associated with insulin resistance in children. Metabolism (2007) 1.03